Mitterer, Wolfgang
Binder, Christoph
Blassnig-Ezeh, Anya
Auer-Hackenberg, Lorenz
Berger, Angelika
Simma, Burkhard
Wald, Martin
Lee, Martin
Kiechl-Kohlendorfer, Ursula https://orcid.org/0000-0003-0433-6196
Article History
Received: 20 March 2021
Accepted: 10 July 2021
First Online: 31 July 2021
Declarations
:
: The present study was approved by the ethics committees of all four study sites (Ethics Committee of the Medical University of Innsbruck, Ethics Committee of the Federal State Salzburg, Ethics Committee of the Medial University of Vienna and Vienna General Hospital, Ethics Committee of the Federal State Vorarlberg). Written informed consent prior to enrollment will be obtained for all participants.
: The authors are willing to provide an English version of the informed consent form if requested. A designated “Biosampling Manual” concerning all biosampling procedures related to the NEOVASC trial can also be submitted on request.
: M.L. is an employee of Prolacta Bioscience, Inc. The authors declare that they have no further competing interests.